Close Menu

NEW YORK – Biocept reported after the close of the market on Wednesday that its third quarter revenues nearly doubled year over year on strong growth in the number of commercial samples received.

For the three months ended Sept 30, the San Diego-based company posted $1.5 million in revenues compared to $761,591 in Q3 2018.The number of commercial samples received in the recently completed quarter grew 66 percent year over year, it said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg Law writes that the Genetic Information Nondiscrimination Act may work better as a privacy, rather than anti-discrimination, law.

TechCrunch reports that Linda Avey has a new personal genomics startup that's focusing on India.

A new report finds that though the US has increased its activity in science and engineering, its global share of that activity has fallen in some areas, according to Inside Higher Ed.

In Nature this week: genomic analysis of rapeseed, universal target enrichment method for metagenomic sequencing, and more.